A Federal Court Just Halted Use of a Highly Controversial Herbicide

Farmers planning to spray their fields with dicamba got a rude shock this week.

simazoran/Getty

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

On Wednesday afternoon, the 9th Circuit Court of Appeals in San Francisco made a ruling that sent shockwaves through Midwestern and Southern farm country: It vacated the Environmental Protection Agency’s registrations of an herbicide that has surged in use in recent years—and generated massive controversy for its tendency to drift off-target and damage crops in neighboring fields and other foliage. 

The chemical, dicamba, has been around since 1962, but had largely fallen out of favor, because of its tendency to stray. But in 2016, seed/pesticide titan Monsanto—which has since been subsumed by German chemical giant Bayer—released seeds for soybean crops engineered to withstand dicamba and its longtime blockbuster herbicide, glyphosate. Throughout the Midwestern soybean belt and southern cotton belt, farmers had since the mid-1990s been planting seeds engineered to withstand glyphosate, which at first made weed control easy but quickly (through simple evolution) gave rise to a torrent of weeds that could withstand glyphosate, too. The pitch: Monsanto’s Roundup Ready Xtend soybeans and cotton would allow farmers to hit their crops with glyphosate and dicamba, with the latter slaying weeds that had developed resistance to the former. 

To address dicamba’s propensity to waft off-target, Monsanto rolled out a new “low-volatility” formulation, which, the company insisted, would kill only targeted weeds if used correctly. The EPA registered Monsanto’s new-fangled dicamba, along with similar versions from rival agrichmical players Bayer and DuPont (which has since combined with Dow and now does agribusiness as Corteva). 

The trouble started immediately. In 2017, 2018, and 2019, farmers in the South and Midwest reported millions of acres of damaged crops from wayward dicamba. Public-university weed scientists—normally not ones to make headlines—sounded the alarm, revealing that the EPA had registered the products without proper vetting and warning that drift was inevitable. Monsanto’s response: It attacked the credibility of the scientists. Through it all, Monsanto, now Bayer, denied the problem, blaming any drift damage on farmer error, not its own products. Aggrieved farmers argued with neighbors, resulting in a bevy of lawsuits and even a fatal shooting. Yet sales of Roundup Ready Xtend seeds boomed, at least in part because many farmers figured just paying up for dicamba-resistant seeds was preferable to watching their soybeans and cotton droop from off-target herbicide.

The EPA, meanwhile, stayed on the agrichemical industry’s side, and this year, “60 million acres of dicamba-tolerant cotton and soybeans were slated for 2020 planting,” reports Emily Unglesbee, reporter for the trade journal DTN. That’s a land mass equal to more than half the size of California.

Most of these crops are already planted, and we’re moving into the season when farmers would be spraying dicamba to clear resistant weeds. The 9th Circuit Court of Appeals decision to “vacate”—essentially, nullify—the EPA’s approval of these products likely means an abrupt halt to that. The decision rebukes the EPA’s handling of the dicamba mess from the start. The agency “substantially understated” the acreage planted with dicamba-tolerant crops in 2018, refused to acknowledge the extent of crop damage, and “entirely failed to acknowledge the substantial risk that the registrations would have anticompetitive economic effects in the soybean and cotton industries”—a reference to the fact that some farmers felt compelled to buy Bayer’s seeds to avoid damage from dicamba. The kicker: The EPA “entirely failed to acknowledge the risk” that the product would “tear the social fabric of farming communities.”

The ruling leaves farmers who have planted the seeds in a tough spot, as the judges acknowledged. “We acknowledge the difficulties these growers may have in finding effective and legal herbicides to protect their [dicamba-tolerant] crops,” the ruling states. “They have been placed in this situation through no fault of their own. However, the absence of substantial evidence to support the EPA’s decision compels us to vacate the registrations.” Drift aside, glyphosate-resistant weeds are rampant, and thousands of soybean and cotton farmers had stocked up on dicamba to zap them.

The EPA, for its part, is mulling what to tell them. “EPA is currently reviewing the court decision and will move promptly to address the Court’s order,” an agency spokesman said in a Friday afternoon email. 

For its part, Bayer denounced the ruling in a statement. “We strongly disagree with the ruling and are assessing our next steps,” the release stated. “We will also await direction from the EPA on actions it may take in response to the ruling.”

US Department of Agriculture secretary Sonny Perdue urged the EPA to defy the court ruling. (The USDA does not regulate pesticide application.) 

“I encourage the EPA to use any available flexibilities to allow the continued use of already purchased dicamba products, which are a critical tool for American farmers to combat weeds resistant to many other herbicides, in fields that are already planted,” Perdue’s statement reads. 

No so fast, says Fertilizer & Chemical Association, a trade group representing agrichemical dealers in that the nation’s number-one soybvean-producing state. In a Thursday statement, the groups says it reached out to the Illinois Department of Agriculture for guidance. “IDA legal counsel has looked at the US 9th Circuit Court ruling on dicamba, and believes it clearly calls for the stop of use, sale and distribution of all uses” of the chemical, the group stated, adding that “we ask for our members to abide by this determination and help communicate this serious message.” 

The coalition of farmers and conservationists who brought the case against dicamba celebrated the ruling. “The decision is a massive win for farmers and the environment,” said George Kimbrell of the Center for Food Safety, lead counsel in the case. “It is good to be reminded that corporations like Monsanto and the Trump Administration cannot escape the rule of law, particularly at a time of crisis like this. Their day of reckoning has arrived.”

The Ninth Circuit ruling isn’t the only rough news dicamba has generated in recent months, overshadowed by coverage of the coronavirus pandemic and police-brutality unrest. In a paper published on May 1, a group of National Institute of Environmental Health Sciences and National Cancer Institute scientists a major ongoing research project on pesticides and concluded that people exposed to dicamba in agricultural settings showed “elevated risk” of liver cancer. 

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate